insights from industryBernd GleixnerDivision President AutomationBruker Biopsin News Medical speaks to Bernd Gleixner, Division President Automation at Bruker Biospin, about the future of lab ...
Increased patient testing and less lab staff to perform manual tasks have created a bottleneck for care Now, automation found in high-volume labs is accessible no matter a lab’s footprint or volume ...
In Vivan Therapeutics’ laboratory, scientists were spending hours manually analyzing fly pupae - tiny organisms that hold critical data for cancer drug testing. Each vial of pupae required precise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback